ABVX Abivax SA
$88.93▲ +2.81%
Healthcare
Other
Volume 205.6K
Avg Volume (10D) 1.10M
Key Metrics & Fundamentals
Market Cap
$7.79B
P/E Ratio
–
Div Yield
0.00%
52W Range
69.81 - 148.83
% vs 50 MA
-15.74%
% vs 200 MA
-24.60%
RSI-14
38.4
MACD Histogram
+0.7800
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$52.10M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$80.32M
COGS
–
Operating Exp
$84.11M
Operating Income
-$84.11M
EBIT
-$84.11M
Pretax Income
-$123.51M
Net Income
-$117.43M
EPS (Diluted)
-1.47
Price & Volume History
Loading chart…
Recent News
Abivax (ABVX): Cleared Safety Overhang and Phase 3 Data De-Risk Path to Commercialization
Insider Monkey · Oct 7, 2026 11:02 AM ET
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
GlobeNewswire · Sep 30, 2026 4:05 PM ET
ABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About
Simply Wall St. · Sep 27, 2026 5:09 AM ET
ABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers
Simply Wall St. · Sep 26, 2026 3:08 PM ET
ABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch?
Insider Monkey · Sep 26, 2026 12:03 AM ET
Wedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating
MT Newswires · Sep 22, 2026 6:32 AM ET
Abivax Says Chris Rabbat to Succeed Fabio Cataldi as Chief Medical Officer
MT Newswires · Sep 21, 2026 4:30 PM ET
Abivax Presents Business Updates and First Half 2026 Financial Results
GlobeNewswire · Sep 21, 2026 4:05 PM ET
4 Biotech Stocks to Watch as Potential Takeover Targets
Zacks · Sep 18, 2026 12:31 PM ET
Earnings To Watch: Abivax SA (XPAR:ABVX) Reports Q2 2026 Result
GuruFocus.com · Sep 11, 2026 9:15 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ABVX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.